Compile Data Set for Download or QSAR
Report error Found 107 Enz. Inhib. hit(s) with all data for entry = 1852
TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344295((1R*,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- ...)
Affinity DataIC50: 40nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344365((1S,3S*)-3-(1- (Difluoromethyl)-1H- indazol-6-yl)-...)
Affinity DataIC50: 46nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345231((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 48nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344298((1R*,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- ...)
Affinity DataIC50: 50nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345230((1S,3R*)-3-(7-Fluoro-1- methyl-1H-indazol-6-yl)-1-...)
Affinity DataIC50: 55nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345218((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 59nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345232((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 62nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344364((1S,3R*)-3-(1- (Difluoromethyl)-1H- indazol-6-yl)-...)
Affinity DataIC50: 72nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344377((1S,3R*)-3-(7-fluoro-1H-indazol-6-yl)-1-(3-fluoro-...)
Affinity DataIC50: 73nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345221((1S,3R*)-1-(3-Fluoro-2-methylphenyl)-N-hydroxy-3-(...)
Affinity DataIC50: 74nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345222((1S,3S*)-3- (Benzo[d]thiazol-2-yl)-1- (3-fluoro-2-...)
Affinity DataIC50: 80nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344359((1S,3R*)-3-(1-(2-(diethylamino)ethyl)-1H-pyrazol-4...)
Affinity DataIC50: 82nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344368((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 82nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345195((1S,3R*)-1-(3-fluoro-2-methylphenyl)-N-hydroxy-3-(...)
Affinity DataIC50: 90nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345233((1S,3R*)-1-(3,4-difluoro-2-methylphenyl)-N-hydroxy...)
Affinity DataIC50: 90nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344354((1S,3R*)-3-(1-(Difluoromethyl)-1H-pyrazol-4-yl)-1-...)
Affinity DataIC50: 95nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344367((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 98nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344297((1S*,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- ...)
Affinity DataIC50: 100nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345156((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 100nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345153((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 110nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345160((1S,3R*)-3-(2- (Difluoromethyl)-2H- indazol-6-yl)-...)
Affinity DataIC50: 110nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345217((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 110nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345229((1S,3S*)-3-(7-Fluoro-1- methyl-1H-indazol-6-yl)-1-...)
Affinity DataIC50: 110nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345243((1S,3S)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3-...)
Affinity DataIC50: 130nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344301((1S,3R*)-1-(3-Fluoro-2- methyl-phenyl)-3-(5- fluor...)
Affinity DataIC50: 140nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344355((1S,3R*)-1-(3-fluoro-2-methylphenyl)-N-hydroxy-3-(...)
Affinity DataIC50: 140nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344366((1S,3R*)-1-(3-fluoro-2-methylphenyl)-N-hydroxy-3-(...)
Affinity DataIC50: 140nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344369((1S,3R*)-3-(2-cyclopropyl-1-oxoisoindolin-5-yl)-1-...)
Affinity DataIC50: 140nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345239((1S,3S)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3-...)
Affinity DataIC50: 140nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344300((1S,3S*)-1-(3-Fluoro-2- methyl-phenyl)-3-(5- fluor...)
Affinity DataIC50: 150nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344323(1-(3,4-Difluoro-2-methylphenyl)-N- hydroxycyclopen...)
Affinity DataIC50: 150nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345228((1S,3R)-3-(5-Fluoro-1-methyl-1H-indazol-6-yl)-1-(3...)
Affinity DataIC50: 150nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344363(N-((R)-1- (Dipropylamino)propan-2- yl)-4-((1S*,3S)...)
Affinity DataIC50: 160nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345223((1S,3R*)-3- (Benzo-[d]thiazol-2-yl)-1- (3-fluoro-2...)
Affinity DataIC50: 160nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345241((1S,3S)-1-(3-Fluoro-2- methylphenyl)-3-((5- fluoro...)
Affinity DataIC50: 160nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345242((1S,3R)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3-...)
Affinity DataIC50: 160nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344299((+-)-(1S*,3S*)1-(3-fluoro-2-methylphenyl)-N-hydrox...)
Affinity DataIC50: 170nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344357((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 170nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344292(1-(3-fluoro-2-methylphenyl)-N-hydroxy-3-(pyridin-3...)
Affinity DataIC50: 190nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344353((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-3-(5-fluoro-...)
Affinity DataIC50: 190nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344304((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-3-(5- fluoro...)
Affinity DataIC50: 200nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344362(N-((R)-1- (Dipropylamino)propan-2- yl)-4-((1R*,3S)...)
Affinity DataIC50: 200nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345240((1S,3R)-1-(3-Fluoro-2- methylphenyl)-3-((5- fluoro...)
Affinity DataIC50: 200nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345173((1S,3S*)-3-(2- (Difluoromethyl)-2H- indazol-6-yl)-...)
Affinity DataIC50: 220nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344305((1S,3R*)-1-(3-Fluoro-2- methylphenyl)-3-(5- fluoro...)
Affinity DataIC50: 240nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344351((1S,3R)-3-(2-cyclopropyl-5-fluoropyridin-3-yl)-1-(...)
Affinity DataIC50: 240nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345244((1S,3S)-1-(3-fluoro-2-methylphenyl)-3-((4-fluorobe...)
Affinity DataIC50: 240nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344358((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 250nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM344311(1-(3-fluoro-2-methylphenyl)-N-hydroxycyclopentanec...)
Affinity DataIC50: 270nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

TargetHistone deacetylase 4(Human)
Chdi Foundation

US Patent
LigandPNGBDBM345220((1S,3S*)-1-(3-Fluoro-2- methylphenyl)-N-hydroxy- 3...)
Affinity DataIC50: 270nMAssay Description:The potency of Class IIa Histone Deacetylase (HDAC) inhibitors is quantified by measuring the Histone Deacetylase 4 (HDAC4) catalytic domain enzymati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/20/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 107 total ) | Next | Last >>
Jump to: